Two decades of molecular surveillance in Kenya reveal shifting <i>Plasmodium falciparum</i> drug resistance mutations linked to frontline drug changes
George A. Tollefson(Brown University), Hoseah M. Akala(United States Army Medical Research Directorate - Africa), John Michael Ong’echa(Kenya Medical Research Institute), Edwin W. Mwakio(United States Army Medical Research Directorate - Africa), Gladys Chemwor(United States Army Medical Research Directorate - Africa), Benjamin Opot(United States Army Medical Research Directorate - Africa), Jackline A. Juma(United States Army Medical Research Directorate - Africa), Bernhards Ogutu, Dennis W. Juma(United States Army Medical Research Directorate - Africa), Abebe A. Fola(John Brown University), Rebecca M. Crudale(Brown University), Raphael Okoth(United States Army Medical Research Directorate - Africa), Titus Maina(Brown University), Jeffrey A. Bailey(John Brown University)
Cited by 0
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
|Nature Microbiology|2023|190
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
|The Journal of Infectious Diseases|2018|147